Kairos Pharma, Ltd.
KAPA
$1.66
$0.000.00%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.45% | 1.63% | 253.07% | 73.30% | 14,347.62% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.55% | 160.00% | 34.21% | 140.00% | 417.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -76.00% | -73.73% | -70.44% | -30.23% | -- |
| Total Current Assets | -34.41% | -26.56% | 29.22% | 40.36% | 12,634.21% |
|
|
|||||
| Total Current Assets | -34.41% | -26.56% | 29.22% | 40.36% | 12,634.21% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -87.91% | -72.07% | -61.07% | -52.98% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -24.23% | -24.99% | -20.77% | -- | 145.22% |
| Total Assets | -33.22% | -27.63% | 13.38% | 61.19% | 547.86% |
|
|
|||||
| Total Accounts Payable | -60.80% | -46.46% | -79.94% | -73.73% | -76.70% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -60.80% | -46.46% | -79.94% | -75.96% | -77.52% |
|
|
|||||
| Total Current Liabilities | -60.80% | -46.46% | -79.94% | -75.96% | -77.52% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -60.80% | -46.46% | -79.94% | -75.96% | -81.65% |
|
|
|||||
| Common Stock & APIC | 22.86% | 26.93% | 51.59% | 84.12% | 323.22% |
| Retained Earnings | -50.48% | -57.94% | -61.79% | -64.61% | -69.40% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -30.12% | -25.50% | 32.77% | 130.01% | 325.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.12% | -25.50% | 32.77% | 130.01% | 325.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.12% | -25.50% | 32.77% | 130.01% | 325.96% |
|
|
|||||